Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMCSamsungVolvo
Webinar :Join an expert panel for a webinar on Smart investments for a secure retirement January 28, 2021. Register now!
you are here: HomeNewsBusiness

Coronavirus relief: MFIs write to Sidbi, RBI seeking relaxation in refinance scheme eligibility terms

On April 17, announcing the second round of COVID-19 relief measures, RBI Governor Shaktikanta Das had launched refinancing support to the tune of Rs 50,000 crore through all India financial institutions such as NABARD, SIDBI and NHB.

April 27, 2020 / 05:18 PM IST
LIVE updates of the Reserve Bank of India (RBI)'s Monetary Policy Committee (MPC) decisions

LIVE updates of the Reserve Bank of India (RBI)'s Monetary Policy Committee (MPC) decisions


After finding the terms of special refinance facility announced by the Small Industries Development Bank of India (SIDBI) under the Reserve Bank of India's liquidity scheme too stringent, microfinance institutions (MFIs) have sought relaxations in the scheme. In a letter written by Sadhan, a body of microlenders, to Sidbi and the RBI, microlenders have requested to include lower-rated companies in the scheme besides increasing the repayment period of the loan.

On April 17, announcing the second round of COVID-19 relief measures, RBI Governor Shaktikanta Das had announced refinancing support to the tune of Rs 50,000 crore through all India financial institutions such as NABARD, SIDBI and NHB.

The central bank said NABARD will be given Rs 25,000 crore for refinancing regional rural banks (RRBs), SIDBI will be given Rs 15,000 crore and Rs 10,000 crore will be given to NHB for supporting housing finance companies (HFCs). Advances under this facility will be charged at the RBI's policy repo rate at the time of availment, the RBI said.








These two conditions will render the majority of MFIs and small companies ineligible for the scheme. Sadhan has requested to bring down the rating requirement to BB to enable more institutions to be made eligible, citing that non-NBFC-MFI consider only MFI grading, as most of them do not get themselves rated due to the costs involved.

Also, microlenders have requested to extend the repayment period to atleast 12 months, or ideally to 18-24 months. “The 90-day period fixed is too short for the MFIs to use this facility to increase their loaning, or even to smoothen their liquidity,” Sadhan letter says. Moneycontrol has reviewed the letter. Sidbi notified the scheme after it received Rs 15,000 crore from the RBI under the special Covid-19 liquidity measure.

Out of the 215 members of Sadhan, only 30 MFIs have even BBB- rating. There are 66 NBFC-MFIs under Sadhan. If the rating stipulation can be up to BB, many of these companies will benefit since very few have BBB-. “One should understand the profile of these companies. A good chunk of the microlenders are not mainstream companies,” said P Satish, executive director of Sadhan.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

MFIs typically lend to low-income borrowers, who are mostly daily-wage earners or run microbusinesses. These loans are given for 18-24 months at a rate of 21-23 percent. The average loan ticket size is around Rs 30,000. Meeting the 90-day repayment requirement is impossible for NBFC-MFIs and MSMEs to comply since their cash flows have dried up severely. The bigger NBFCs may have the bargaining power to negotiate rollover of these loans beyond 90-days that will then lead to evergreening of loans. But small firms with low rating do not stand a chance.

Banks typically prefer big companies with top ratings for giving loans due to the perceived high-risk. Banks fear that once the lockdown period is over, MFIs will see large scale defaults and the RBI’s temporary measures may not come to their rescue then. The lending decisions will be questioned at that point when bad loans spike.
Dinesh Unnikrishnan
first published: Apr 27, 2020 05:14 pm

stay updated

Get Daily News on your Browser
Sections